{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:05:32Z","timestamp":1789365932059,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01919-1","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:00:45Z","timestamp":1789362045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The deubiquitinase YOD1 in renal tubular epithelial cells promotes diabetic kidney disease by stabilizing KEAP1"],"prefix":"10.1038","author":[{"given":"Qing-qing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di-yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-zheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yi","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103435","volume":"78","author":"S Ye","year":"2024","unstructured":"Ye S, Zhang M, Zheng X, Li S, Fan Y, Wang Y, et al. YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease. Redox Biol. 2024;78:103435.","journal-title":"Redox Biol"},{"key":"1919_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56891-x","volume":"16","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Cao Y, Jian Y, Hu H, Yang Q, Hao Y, et al. CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease. Nat Commun. 2025;16:1528.","journal-title":"Nat Commun"},{"key":"1919_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102241","volume":"6","author":"HJ Sun","year":"2025","unstructured":"Sun HJ, Lu QB, Liu SJ, Fu X, Yu CL, Su JB, et al. Phosphoglycerate kinase 1 contributes to diabetic kidney disease through enzyme-dependent and independent manners. Cell Rep Med. 2025;6:102241.","journal-title":"Cell Rep Med"},{"key":"1919_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.kint.2024.11.026","volume":"107","author":"E Folestad","year":"2025","unstructured":"Folestad E, Mehlem A, Ning FC, Oosterveld T, Palombo I, Singh J, et al. Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease. Kidney Int. 2025;107:492\u2013507.","journal-title":"Kidney Int"},{"key":"1919_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154890","volume":"124","author":"CA Ricciardi","year":"2021","unstructured":"Ricciardi CA, Gnudi L. Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies. Metabolism. 2021;124:154890.","journal-title":"Metabolism"},{"key":"1919_CR6","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.7150\/ijbs.81892","volume":"19","author":"H Wang","year":"2023","unstructured":"Wang H, Liu D, Zheng B, Yang Y, Qiao Y, Li S, et al. Emerging role of ferroptosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities. Int J Biol Sci. 2023;19:2678\u201394.","journal-title":"Int J Biol Sci"},{"key":"1919_CR7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1681\/ASN.2013070810","volume":"25","author":"JC Jha","year":"2014","unstructured":"Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol. 2014;25:1237\u201354.","journal-title":"J Am Soc Nephrol"},{"key":"1919_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12933-024-02427-4","volume":"23","author":"K Adeshara","year":"2024","unstructured":"Adeshara K, Di Marco E, Bordino M, Gordin D, Bernardi L, Cooper ME, et al. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia. Cardiovasc Diabetol. 2024;23:350.","journal-title":"Cardiovasc Diabetol"},{"key":"1919_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2019.09.003","volume":"145","author":"S Qiao","year":"2019","unstructured":"Qiao S, Liu R, Lv C, Miao Y, Yue M, Tao Y, et al. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR\/beta-TrcP\/Nrf2 pathway. Free Radic Biol Med. 2019;145:118\u201335.","journal-title":"Free Radic Biol Med"},{"key":"1919_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/procel\/pwad045","volume":"15","author":"X Sheng","year":"2024","unstructured":"Sheng X, Xia Z, Yang H, Hu R. The ubiquitin codes in cellular stress responses. Protein Cell. 2024;15:157\u201390.","journal-title":"Protein Cell"},{"key":"1919_CR11","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","volume":"18","author":"S Han","year":"2022","unstructured":"Han S, Wang R, Zhang Y, Li X, Gan Y, Gao F, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18:2292\u2013303.","journal-title":"Int J Biol Sci"},{"key":"1919_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1919_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166713","volume":"1869","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Chen X, Lin Y, Li Z, Su X, Fan S, et al. USP25 inhibits renal fibrosis by regulating TGFbeta-SMAD signaling pathway in Ang II-induced hypertensive mice. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166713.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1919_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07136-0","volume":"15","author":"R Tu","year":"2024","unstructured":"Tu R, Ma J, Chen Y, Kang Y, Ren D, Cai Z, et al. USP7 depletion potentiates HIF2alpha degradation and inhibits clear cell renal cell carcinoma progression. Cell Death Dis. 2024;15:749.","journal-title":"Cell Death Dis"},{"key":"1919_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44228-5","volume":"14","author":"LK Chu","year":"2023","unstructured":"Chu LK, Cao X, Wan L, Diao Q, Zhu Y, Kan Y, et al. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury. Nat Commun. 2023;14:8393.","journal-title":"Nat Commun"},{"key":"1919_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167331","volume":"1870","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Zhang R, Wang Y, Li T, Xue J, Chen Z. FOXQ1, deubiquitinated by USP10, alleviates sepsis-induced acute kidney injury by targeting the CREB5\/NF-kappaB signaling axis. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167331.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1919_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07673-2","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Lu Y, Zhu R, Xi P, Yang Z, Zhang Z, et al. The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma. Cell Death Dis. 2025;16:334.","journal-title":"Cell Death Dis"},{"key":"1919_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06731-5","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Fan C, Liu J, Zhang S, Tang H, Liu Y, et al. YOD1 protects against MRSA sepsis-induced DIC through Lys33-linked deubiquitination of NLRP3. Cell Death Dis. 2024;15:360.","journal-title":"Cell Death Dis"},{"key":"1919_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.apsb.2024.11.020","volume":"15","author":"J Sun","year":"2025","unstructured":"Sun J, Chen F, She L, Zeng Y, Tang H, Ye B, et al. YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer\u2019s disease. Acta Pharm Sin B. 2025;15:331\u201348.","journal-title":"Acta Pharm Sin B"},{"key":"1919_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si S, Liu H, Xu L, Zhan S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16:84.","journal-title":"Genome Med"},{"key":"1919_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"1919_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1205834","volume":"14","author":"A Cai","year":"2023","unstructured":"Cai A, Shen J, Yang X, Shao X, Gu L, Mou S, et al. Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels. Front Immunol. 2023;14:1205834.","journal-title":"Front Immunol"},{"key":"1919_CR23","doi-asserted-by":"crossref","unstructured":"Sun ZJ, Chang DY, Chen M, Zhao MH. Deficiency of CFB attenuates renal tubulointerstitial damage by inhibiting ceramide synthesis in diabetic kidney disease. JCI Insight. 2022;7:e156748.","DOI":"10.1172\/jci.insight.156748"},{"key":"1919_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13287-020-01822-4","volume":"11","author":"G Sun","year":"2020","unstructured":"Sun G, Ding B, Wan M, Chen L, Jackson J, Atala A. Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro. Stem Cell Res Ther. 2020;11:309.","journal-title":"Stem Cell Res Ther"},{"key":"1919_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41401-019-0297-6","volume":"41","author":"L Du","year":"2020","unstructured":"Du L, Wang L, Wang B, Wang J, Hao M, Chen YB, et al. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1\/Nrf2 signaling. Acta Pharmacol Sin. 2020;41:358\u201372.","journal-title":"Acta Pharmacol Sin"},{"key":"1919_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"1919_CR27","doi-asserted-by":"crossref","unstructured":"Zhou Y, Chen Y, Shi Y, Wu L, Tan Y, Li T, et al. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1\/NRF2 signaling pathway. J Clin Invest. 2023;133:e158705.","DOI":"10.1172\/JCI158705"},{"key":"1919_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu8422","volume":"11","author":"B Ye","year":"2025","unstructured":"Ye B, Lin W, Jiang Y, Zheng Z, Jin Y, Xu D, et al. Cardiomyocyte-derived YOD1 promotes pathological cardiac hypertrophy by deubiquitinating and stabilizing STAT3. Sci Adv. 2025;11:eadu8422.","journal-title":"Sci Adv"},{"key":"1919_CR29","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","volume":"12","author":"X Shao","year":"2022","unstructured":"Shao X, Chen Y, Wang W, Du W, Zhang X, Cai M, et al. Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RARalpha and eradicates acute promyelocytic leukemia cells. Acta Pharm Sin B. 2022;12:1856\u201370.","journal-title":"Acta Pharm Sin B"},{"key":"1919_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03881-0","volume":"25","author":"J Zhao","year":"2025","unstructured":"Zhao J, Guo X, Li H, Chen Y, Du J, Zhang J, et al. Regulation of disease signaling by YOD1: potential implications for therapeutic strategies. Cancer Cell Int. 2025;25:232.","journal-title":"Cancer Cell Int"},{"key":"1919_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405325","volume":"11","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tian M, Zhang M, Li C, Wang X, Long Y, et al. Forkhead box protein K1 promotes chronic kidney disease by driving glycolysis in tubular epithelial cells. Adv Sci. 2024;11:e2405325.","journal-title":"Adv Sci"},{"key":"1919_CR32","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1111\/jcmm.16857","volume":"25","author":"S Zhou","year":"2021","unstructured":"Zhou S, Ling X, Meng P, Liang Y, Shen K, Wu Q, et al. Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing. J Cell Mol Med. 2021;25:8957\u201372.","journal-title":"J Cell Mol Med"},{"key":"1919_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41581-021-00394-7","volume":"17","author":"H Scholz","year":"2021","unstructured":"Scholz H, Boivin FJ, Schmidt-Ott KM, Bachmann S, Eckardt KU, Scholl UI, et al. Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nat Rev Nephrol. 2021;17:335\u201349.","journal-title":"Nat Rev Nephrol"},{"key":"1919_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105294","volume":"107","author":"ZL Li","year":"2024","unstructured":"Li ZL, Li XY, Zhou Y, Wang B, Lv LL, Liu BC. Renal tubular epithelial cells response to injury in acute kidney injury. EBioMedicine. 2024;107:105294.","journal-title":"EBioMedicine"},{"key":"1919_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"BC Liu","year":"2018","unstructured":"Liu BC, Tang TT, Lv LL, Lan HY. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93:568\u201379.","journal-title":"Kidney Int"},{"key":"1919_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.kint.2022.02.038","volume":"102","author":"YEJ Xie","year":"2022","unstructured":"Xie YEJ, Cai H, Zhong F, Xiao W, Gordon RE, Wang L, et al. Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells. Kidney Int. 2022;102:293\u2013306.","journal-title":"Kidney Int"},{"key":"1919_CR37","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.7150\/ijbs.109799","volume":"21","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Chen J, Xue X, Ma X, Zhang S, Wang M, et al. SESN2 inhibits tubular exosome secretion and diabetic kidney disease progression by restoring the autophagy\u2012lysosome pathway. Int J Biol Sci. 2025;21:4215\u201330.","journal-title":"Int J Biol Sci"},{"key":"1919_CR38","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/ndt\/gfs260","volume":"27","author":"SC Tang","year":"2012","unstructured":"Tang SC, Lai KN. The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant. 2012;27:3049\u201356.","journal-title":"Nephrol Dial Transplant"},{"key":"1919_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102260","volume":"50","author":"L Liu","year":"2022","unstructured":"Liu L, Bai F, Song H, Xiao R, Wang Y, Yang H, et al. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol. 2022;50:102260.","journal-title":"Redox Biol"},{"key":"1919_CR40","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1080\/15548627.2020.1824694","volume":"17","author":"C Yang","year":"2021","unstructured":"Yang C, Chen XC, Li ZH, Wu HL, Jing KP, Huang XR, et al. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy. Autophagy. 2021;17:2325\u201344.","journal-title":"Autophagy"},{"key":"1919_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2085-0","volume":"10","author":"C Zheng","year":"2019","unstructured":"Zheng C, Huang L, Luo W, Yu W, Hu X, Guan X, et al. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice. Cell Death Dis. 2019;10:848.","journal-title":"Cell Death Dis"},{"key":"1919_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.kint.2022.09.024","volume":"103","author":"S Krishnan","year":"2023","unstructured":"Krishnan S, Manoharan J, Wang H, Gupta D, Fatima S, Yu Y, et al. CD248 induces a maladaptive unfolded protein response in diabetic kidney disease. Kidney Int. 2023;103:304\u201319.","journal-title":"Kidney Int"},{"key":"1919_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/en.2014-1381","volume":"156","author":"KP Huang","year":"2015","unstructured":"Huang KP, Chen C, Hao J, Huang JY, Liu PQ, Huang HQ. AGEs-RAGE system down-regulates Sirt1 through the ubiquitin-proteasome pathway to promote FN and TGF-beta1 expression in male rat glomerular mesangial cells. Endocrinology. 2015;156:268\u201379.","journal-title":"Endocrinology"},{"key":"1919_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49854-1","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fan S, Zhu H, Zhao Q, Fang Z, Xu D, et al. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury. Nat Commun. 2024;15:5441.","journal-title":"Nat Commun"},{"key":"1919_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3982906","volume":"2017","author":"Y Li","year":"2017","unstructured":"Li Y, Huang W, Xu Y, Zhou L, Liang Y, Gao C, et al. CYLD deubiquitinase negatively regulates high glucose-induced NF-kappaB inflammatory signaling in mesangial cells. Biomed Res Int. 2017;2017:3982906.","journal-title":"Biomed Res Int"},{"key":"1919_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.638477","volume":"9","author":"S Zhu","year":"2021","unstructured":"Zhu S, Hou S, Lu Y, Sheng W, Cui Z, Dong T, et al. USP36-mediated deubiquitination of DOCK4 contributes to the diabetic renal tubular epithelial cell injury via Wnt\/beta-catenin signaling pathway. Front Cell Dev Biol. 2021;9:638477.","journal-title":"Front Cell Dev Biol"},{"key":"1919_CR47","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1073\/pnas.1620306114","volume":"114","author":"Y Kim","year":"2017","unstructured":"Kim Y, Kim W, Song Y, Kim JR, Cho K, Moon H, et al. Deubiquitinase YOD1 potentiates YAP\/TAZ activities through enhancing ITCH stability. Proc Natl Acad Sci USA. 2017;114:4691\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1919_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06035-0","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Duan Y, Han W, Cao J, Ye B, Chen P, et al. Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma. Cell Death Dis. 2023;14:517.","journal-title":"Cell Death Dis"},{"key":"1919_CR49","doi-asserted-by":"crossref","unstructured":"Liang Z, Xiang J, Yang G, Liu X, Li L, Li Y, et al. Energy-sensing molecule RORgamma regulates cholesterol metabolism and immune signaling in diabetic kidney disease and aging. Nat Commun. 2026;17:2906.","DOI":"10.1038\/s41467-026-69724-2"},{"key":"1919_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121661","volume":"322","author":"S Su","year":"2023","unstructured":"Su S, Ma Z, Wu H, Xu Z, Yi H. Oxidative stress as a culprit in diabetic kidney disease. Life Sci. 2023;322:121661.","journal-title":"Life Sci"},{"key":"1919_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","volume":"11","author":"L Xiao","year":"2017","unstructured":"Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1. Redox Biol. 2017;11:297\u2013311.","journal-title":"Redox Biol"},{"key":"1919_CR52","doi-asserted-by":"crossref","unstructured":"Wang N, Zhang C. Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants. 2024;13:455.","DOI":"10.3390\/antiox13040455"},{"key":"1919_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2025.2529618","volume":"30","author":"X Liu","year":"2025","unstructured":"Liu X, Chen C, Zhu S, Luo X, Gao L, Hu Z, et al. ACSF2-PGK1 interaction promotes ferroptosis in renal tubular epithelial cells of diabetic nephropathy by regulating Keap1\/Nrf2 signaling. Redox Rep. 2025;30:2529618.","journal-title":"Redox Rep"},{"key":"1919_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305563","volume":"11","author":"H Wang","year":"2024","unstructured":"Wang H, Yu X, Liu D, Qiao Y, Huo J, Pan S, et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2\/HO-1 signaling pathway in diabetic nephropathy. Adv Sci. 2024;11:e2305563.","journal-title":"Adv Sci"},{"key":"1919_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.12.088","volume":"195","author":"Q Lu","year":"2023","unstructured":"Lu Q, Yang L, Xiao JJ, Liu Q, Ni L, Hu JW, et al. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK\/NRF2 pathway. Free Radic Biol Med. 2023;195:89\u2013102.","journal-title":"Free Radic Biol Med"},{"key":"1919_CR56","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.ekir.2024.07.020","volume":"9","author":"EY Hernandez-Cruz","year":"2024","unstructured":"Hernandez-Cruz EY, Aparicio-Trejo OE, Hammami FA, Bar-Shalom D, Tepel M, Pedraza-Chaverri J, et al. N-acetylcysteine in kidney disease: molecular mechanisms, pharmacokinetics, and clinical effectiveness. Kidney Int Rep. 2024;9:2883\u2013903.","journal-title":"Kidney Int Rep"},{"key":"1919_CR57","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.05.024","volume":"187","author":"Q Li","year":"2022","unstructured":"Li Q, Liao J, Chen W, Zhang K, Li H, Ma F, et al. NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway. Free Radic Biol Med. 2022;187:158\u201370.","journal-title":"Free Radic Biol Med"},{"key":"1919_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","volume":"5","author":"DA Abed","year":"2015","unstructured":"Abed DA, Goldstein M, Albanyan H, Jin H, Hu L. Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. Acta Pharm Sin B. 2015;5:285\u201399.","journal-title":"Acta Pharm Sin B"},{"key":"1919_CR59","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98:1169\u2013203.","journal-title":"Physiol Rev"},{"key":"1919_CR60","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","volume":"77","author":"K Lu","year":"2017","unstructured":"Lu K, Alcivar AL, Ma J, Foo TK, Zywea S, Mahdi A, et al. NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction. Cancer Res. 2017;77:2881\u201392.","journal-title":"Cancer Res"},{"key":"1919_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2024.12.036","volume":"227","author":"F Chi","year":"2025","unstructured":"Chi F, Cheng C, Liu K, Sun T, Zhang M, Hou Y, et al. Baicalein disrupts the KEAP1-NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization. Free Radic Biol Med. 2025;227:557\u201369.","journal-title":"Free Radic Biol Med"},{"key":"1919_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2025.2466142","volume":"30","author":"J Yan","year":"2025","unstructured":"Yan J, Gu Q, Li J, Zhou Z, Jiang W, Guan W, et al. MS-275 facilitates osseointegration in osteoporotic rats by mitigating oxidative stress via activation of the miR-200a\/Keap1\/Nrf2 signaling pathway. Redox Rep. 2025;30:2466142.","journal-title":"Redox Rep"},{"key":"1919_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41420-022-01086-2","volume":"8","author":"Q Xu","year":"2022","unstructured":"Xu Q, Liu M, Gu J, Ling S, Liu X, Luo Z, et al. Ubiquitin-specific protease 7 regulates myocardial ischemia\/reperfusion injury by stabilizing Keap1. Cell Death Discov. 2022;8:291.","journal-title":"Cell Death Discov"},{"key":"1919_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","volume":"51","author":"NF Villeneuve","year":"2013","unstructured":"Villeneuve NF, Tian W, Wu T, Sun Z, Lau A, Chapman E, et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Mol Cell. 2013;51:68\u201379.","journal-title":"Mol Cell"},{"key":"1919_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39412-6","volume":"14","author":"C Cai","year":"2023","unstructured":"Cai C, Ma H, Peng J, Shen X, Zhen X, Yu C, et al. USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat Commun. 2023;14:3648.","journal-title":"Nat Commun"},{"key":"1919_CR66","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1038\/s41401-025-01587-7","volume":"46","author":"QS Zheng","year":"2025","unstructured":"Zheng QS, Xiong YQ, Xu JC, Qian JF, Luo W, Wang QY, et al. YOD1 mediates isoproterenol-induced cardiac remodeling by deubiquitinating PKM2 and reducing PKM2 tetramerization in cardiomyocytes. Acta Pharmacol Sin. 2025;46:2938\u201350.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01919-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:01:45Z","timestamp":1789365705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":66,"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01919-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}